FDA to review Helsinn CINV product

FDA accepted for review an NDA from Helsinn Healthcare S.A. (Pazzallo-Lugano, Switzerland) for NEPA to prevent acute and delayed chemotherapy-induced nausea and vomiting (CINV). The PDUFA date is Sept...